Mental Health Across the Menstrual Cycle in Polycystic Ovary Syndrome: Insights and Implications.

IF 5.5 2区医学 Q1 PSYCHIATRY

Current Psychiatry Reports Pub Date : 2024-08-31 DOI:10.1007/s11920-024-01529-w

Phoutdavone Phimphasone-Brady, Kaitlin V Ross, Alexander Z Zhang, Madeleine Sehrt, Kathryn M McKenney, Lindsay G Lebin

{"title":"Mental Health Across the Menstrual Cycle in Polycystic Ovary Syndrome: Insights and Implications.","authors":"Phoutdavone Phimphasone-Brady, Kaitlin V Ross, Alexander Z Zhang, Madeleine Sehrt, Kathryn M McKenney, Lindsay G Lebin","doi":"10.1007/s11920-024-01529-w","DOIUrl":null,"url":null,"abstract":"Purpose of review: We reviewed a wide body of emerging research highlighting the possibility for premenstrual exacerbations of mood symptoms in polycystic ovary syndrome (PCOS).Recent findings: Neuroendocrine dysregulation, sensitivity to ovarian hormone fluctuations as well as higher levels and types of adverse childhood experiences and demographic factors are emerging factors explaining high rates of psychiatric disorders in PCOS. Ovulatory dysfunction, common in PCOS, significantly interferes with one's identity and quality of life. Results on pharmacologic and non-pharmacologic treatments for mood symptoms are mixed, though improvements in the physical sequalae of PCOS could also improve mood symptoms. However, significant improvements on the methodological quality are needed, particularly the evaluation of mood symptoms across the menstrual cycle. Evidence is preliminary on whether there are premenstrual exacerbations of psychiatric symptoms in PCOS. Prospective, longitudinal studies with larger sample sizes are needed to comprehensively understand the psychiatric profile in PCOS.","PeriodicalId":11057,"journal":{"name":"Current Psychiatry Reports","volume":null,"pages":null},"PeriodicalIF":5.5000,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Psychiatry Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11920-024-01529-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: We reviewed a wide body of emerging research highlighting the possibility for premenstrual exacerbations of mood symptoms in polycystic ovary syndrome (PCOS).

Recent findings: Neuroendocrine dysregulation, sensitivity to ovarian hormone fluctuations as well as higher levels and types of adverse childhood experiences and demographic factors are emerging factors explaining high rates of psychiatric disorders in PCOS. Ovulatory dysfunction, common in PCOS, significantly interferes with one's identity and quality of life. Results on pharmacologic and non-pharmacologic treatments for mood symptoms are mixed, though improvements in the physical sequalae of PCOS could also improve mood symptoms. However, significant improvements on the methodological quality are needed, particularly the evaluation of mood symptoms across the menstrual cycle. Evidence is preliminary on whether there are premenstrual exacerbations of psychiatric symptoms in PCOS. Prospective, longitudinal studies with larger sample sizes are needed to comprehensively understand the psychiatric profile in PCOS.

Abstract Image

查看原文本刊更多论文

多囊卵巢综合症患者月经周期中的心理健康：见解与启示。

综述的目的：我们回顾了大量新出现的研究，这些研究强调了多囊卵巢综合征（PCOS）患者经前期情绪症状加重的可能性：神经内分泌失调、对卵巢激素波动的敏感性、较高水平和较多类型的童年不良经历以及人口统计学因素，都是解释多囊卵巢综合征精神障碍高发的新因素。多囊卵巢综合症常见的排卵功能障碍会严重影响患者的身份认同和生活质量。尽管改善多囊卵巢综合症的身体后遗症也能改善情绪症状，但针对情绪症状的药物和非药物治疗结果不一。然而，在方法质量方面还需要有重大改进，特别是对整个月经周期的情绪症状的评估。关于多囊卵巢综合症患者的精神症状是否会在经前期加重，目前尚无初步证据。要全面了解多囊卵巢综合症的精神症状，需要进行样本量更大的前瞻性纵向研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Psychiatry Reports PSYCHIATRY-

CiteScore

11.30

自引率

3.00%

发文量

审稿时长

6-12 weeks

期刊介绍： This journal aims to review the most important, recently published research in psychiatry. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by psychiatric disorders. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as anxiety, medicopsychiatric disorders, and schizophrenia and other related psychotic disorders. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.